Minimal residual disease in acute lymphoblastic leukemia
about
Molecular detection of B-cell neoplasms by specific DNA methylation biomarkersGenome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaA new method for high speed, sensitive detection of minimal residual disease.High-risk childhood acute lymphoblastic leukemiaThe lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia.BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemiaImproved prognosis for older adolescents with acute lymphoblastic leukemia.Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemiaQuantitative detection of the human cervical cancer oncogene for monitoring the minimal residual disease in acute leukemiaRole of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia.Therapy of Philadelphia chromosome-negative acute lymphoblastic leukemia in adults: new paradigms.Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.Adult acute lymphoblastic leukemia: concepts and strategies.Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians.Flow cytometry in hematological disorders.Leukemias in Children.Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group.Acute lymphoblastic leukemia: a comprehensive review and 2017 updateEnhanced sensitivity of flow cytometry for routine assessment of minimal residual disease.Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients.Towards automation of flow cytometric analysis for quality-assured follow-up assessment to guide curative therapy for acute lymphoblastic leukaemia in childrenCharacterizing Deformability of Drug Resistant Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells Using Acoustic Tweezers
P2860
Q28394142-75D199F9-6775-4CCD-8C4A-231AD856DCC8Q28943431-94F58004-5ECB-48E9-A075-A8B3871ABD45Q31030896-32558530-A6D2-431A-AAB7-1B3C01E1517EQ33622837-FC6BBE56-ACE3-4D17-A17B-90DD6F72DE43Q33919296-554CE5E8-5749-44D7-BDB1-20AF83EEDD4AQ34358853-27E74462-4D74-4E38-B533-A47C76974E32Q34449151-08C0AEE3-155D-4137-92D3-B046D19C90D5Q34679298-B012D1B8-FF6E-4682-B37D-47D3FF3E622BQ36371093-8159FF92-8636-45B2-B54F-C289A64F8C2FQ37070953-C3F3A67A-F7BD-468B-BA41-01D43FC9D7D6Q37389544-2F5CE257-A821-4A74-8BCD-D89E233926A8Q37605864-CE6DBFF7-3B9A-4B71-AA48-CC2BF99FF782Q37613872-3CEC5003-C497-4643-BDAC-9F738B9B0658Q37681450-5BBCDABB-A5F4-4437-BCAF-EDC48A1DA28CQ37847072-BBF9D165-D94A-4A9C-A09C-A53D708C7134Q38128814-2CF2F22C-C577-4053-9D96-1D3A8A12CEA2Q38355065-73A2D17E-998B-42FD-BE01-F48D5372A6F1Q38749564-77249B4D-3A51-4EDC-ADF2-A4DDEF961B41Q39406969-97EEC9E4-6305-415E-811E-634DBC699181Q42832364-416CCE54-55C8-44F6-97E1-2DDC76DFFFD2Q43221788-646EB45E-FF44-4E3A-986F-696BF6C75937Q51746464-BD747F6B-7AA2-4733-8AA3-C54ADC9CB2BFQ57566668-6AA7D9FD-C78F-4CE3-8B2A-D4D08FEA91CEQ57794620-9503336B-78C9-4843-AAB5-09124F84E40E
P2860
Minimal residual disease in acute lymphoblastic leukemia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minimal residual disease in acute lymphoblastic leukemia
@en
Minimal residual disease in acute lymphoblastic leukemia.
@nl
type
label
Minimal residual disease in acute lymphoblastic leukemia
@en
Minimal residual disease in acute lymphoblastic leukemia.
@nl
prefLabel
Minimal residual disease in acute lymphoblastic leukemia
@en
Minimal residual disease in acute lymphoblastic leukemia.
@nl
P2860
P1476
Minimal residual disease in acute lymphoblastic leukemia
@en
P2093
Dario Campana
P2860
P304
P356
10.1053/J.SEMINHEMATOL.2008.09.001
P577
2009-01-01T00:00:00Z